VOLUME 22 , ISSUE 2 ( 2018 ) > List of Articles
Vishal Peshattiwar
Keywords : Fondaparinux, heparin-induced thrombocytopenia, thromboprophylaxis treatment
Citation Information : Peshattiwar V. The Fondaparinux Paradox: Fondaparinux-Related Heparin-Induced Thrombocytopenia. Indian J Crit Care Med 2018; 22 (2):116-118.
DOI: 10.4103/ijccm.IJCCM_189_17
License: CC BY-ND 3.0
Published Online: 01-02-2018
Copyright Statement: Copyright © 2018; The Author(s).
Fondaparinux, a pentasaccharide administered for heparin-induced thrombocytopenia (HIT), can lead to the occurrence of thrombocytopenia. This patient underwent aortic stent graft placement for Salmonella paratyphi A-infected abdominal aortic aneurysm. Fondaparinux was administered for anticoagulation that led to a dramatic decline in his platelet counts. Investigations revealed HIT profile, PF4/heparin by particle gel immunoassay to be positive. Fondaparinux, a prescribed anticoagulant for HIT can paradoxically predispose to thrombocytopenia.
© Jaypee Brothers Medical Publishers (P) LTD.
We use cookies on this site to enhance your user experience.
By clicking any link on this page you are giving your consent for us to set cookies.